Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke
Condition(s) studied
Investigational drug(s) / intervention(s)
Perceive, Recall, Plan and Perform-Intervention protocol (PRPP-I): delivered over a 4-week period, in 12 sessions (45/60 min, 3 days a week for 4 weeks) for all patients according to the PRPP-I protocol. The intervention will be carried out by a PRPP-certified occupational therapist working on a Master's degree. It will consist of : * Implementation of training in functional cognitive strategies and meta-prompts through performance in home activities, * Repeated measurement of performance judgment criteria ; * Assessment of cognitive strategies * personalized implementation of the PRPP-I cognitive strategy training protocol. * Collection of feasibility modalities when tracking the intervention (e.g., time, transport, etc.).
Study summary
This pilot experimental study aims to describe the feasibility of a cognitive strategy training protocol : PRPP-I, in activities of daily life across home-based setting for adults with chronic stroke for improvement of independence and quality of life. Aditionnally to examine preliminary effectiveness of PRPP-I protocol within a home-based setting on functional cognitive strategies, independence, quality of life and career burden.
Eligibility
Primary outcome measure(s)
- Feasability — From enrollment to the end of intervention at 4 weeks
Composite outcome examine (1) the recruitment, (2) adherence to the protocol, (3) the implementation of the procedures (delivery) of the intervention and (4) the fidelity to intervention. (1) the adequate recruitment rate will be 9 participants who meet the inclusion criteria, assessed at 24 months; (2) Adherence will be adequate if \> 80% of participants complete the PRPP-I protocol at home (≥80% of sessions) for 4 weeks, assessed at 4 weeks post-intervention; (3) Intervention procedures (delivery) will be assessed based on the implementation of resources for 12 PRPP-I intervention sessions delivered at home over 4 weeks, assessed at 4 weeks post-intervention; (4) Intervention fidelity, according to the PRPP-I protocol (i.e., intervention implementation) will be assessed using a standardized checklist. A procedural fidelity of ≥ 80% will be interpreted as adequate, calculated using the Tate \& Perdices formula of 2019 and in accordance with SCRIBE guidelines.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University Hospital of Toulouse | Toulouse | France | Recruiting |
More University Hospital, Toulouse trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07084025 on ClinicalTrials.gov ↗ ← All trials in France